Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced a significant milestone in its ongoing Phase 2 clinical study, ACTIVATE (clinicaltrials ...
With inactive secondary progressive MS, the ‘quietness’ can be misleading, as the condition is still progressing. Learn which subtle symptoms to tell your doctor about.